Mounjaro Cost: Brand vs Compounded 2026

Quick Answer: Brand Mounjaro has a manufacturer list price of $1,069–$1,080 per month, but what you actually pay depends heavily on your insurance status and which savings programs you use.

Compounded tirzepatide, once a popular $299–$499/month alternative, was eliminated by the FDA in early 2026 when tirzepatide was removed from the drug shortage list. Your real options now range from $25/month (with commercial insurance and the Lilly savings card) to over $1,600/month at retail pharmacies without coverage.

Key Takeaways

• 💊 Brand Mounjaro list price: $1,069–$1,080/month for all dose strengths (2.5mg to 15mg) [1]
• 🏥 With insurance + Lilly savings card: as low as $25/month for eligible patients [1]
• 🏪 Without insurance at retail pharmacies: $1,300–$1,600/month in 2026 [3]
• 💳 GoodRx discount: reduces cost to approximately $995/month [3]
• 🏬 Cheapest major pharmacy: Costco at roughly $995–$1,075/month; most expensive is Walgreens at $1,112–$1,150/month [1]
• 🚫 Compounded tirzepatide is no longer legally available as of 2026 — the FDA removed tirzepatide from the shortage list [7]
• ✅ Best self-pay alternative: Eli Lilly’s Zepbound (same active ingredient, weight loss label) via LillyDirect starting at $349/month [1]
• 📉 Compounded semaglutide (a different GLP-1) remains available from $199–$500/month and is still a legal, lower-cost option [5]
• 📅 18-month treatment costs range from $450 (insurance + savings card) to $18,000+ (GoodRx pricing) [1]

Why Mounjaro Cost Feels Confusing (And How to Cut Through It)

Most people searching for Mounjaro pricing get one number — the list price — and assume that’s what they’ll pay. That assumption can cost you thousands of dollars per year.

The reality is that Mounjaro cost is not one number. It’s a spectrum that starts at $25/month and climbs past $1,600/month depending on four variables: your insurance coverage, which pharmacy you use, which discount programs you qualify for, and whether you’re using Mounjaro for type 2 diabetes or weight loss.

This guide breaks down every tier, explains what happened to compounded tirzepatide in 2026, and tells you exactly which path makes the most financial sense for your situation.

What Is the Actual Mounjaro List Price in 2026?

The manufacturer list price for Mounjaro is $1,069–$1,080 per month for a 28-day supply (four weekly injection pens), regardless of dose strength. [1] This means whether you’re on the starting 2.5mg dose or the maximum 15mg dose, the list price stays the same.

This is important because many patients assume higher doses cost more. They don’t — at least not at the list price level.

However, the list price is not what most people pay at the pharmacy counter. It’s the starting point that insurance companies and pharmacies negotiate from.

Retail pharmacy prices without any discounts or insurance:

Pharmacy	Estimated Monthly Cost (2026)
Costco	~$995–$1,075
CVS	~$1,100–$1,150
Walgreens	~$1,112–$1,150
Retail average	~$1,284–$1,600

Key point: Annual out-of-pocket costs at full retail can reach $19,200 per year — which is why finding the right savings path matters enormously. [3]

6 Best Oral GLP-1 for Weight Loss in 2026

Based on clinical efficacy, FDA status, and current 2026 market availability, here are the top six oral options.

1. Wegovy® Oral Pill (Semaglutide 25mg/50mg)

• Best For: Maximum FDA-approved weight loss.
• Avg. Results: 16.6% body weight reduction in 64 weeks.
• 2026 Status: FDA Approved & Broadly Available.
• Cost: $149 (Intro) to $299 (Maintenance) per month.The Wegovy pill is the “heavy hitter” of the group. Unlike its lower-dose cousin Rybelsus, the 2026 Wegovy pill comes in 25mg and 50mg strengths specifically designed to mimic the high-potency 2.4mg weekly injection.

2. Orforglipron (Lilly’s “Obesity Pill”)

• Best For: Ease of use (No food/water restrictions).
• Avg. Results: 12.4% – 14.7% weight loss.
• 2026 Status: FDA Approval expected Q2 2026.Orforglipron is the most anticipated drug of the year. Unlike semaglutide pills, which require you to wait 30 minutes before eating, Orforglipron can be taken anytime. It is a “small molecule” drug, making it more predictable and often better tolerated by those with sensitive stomachs.

3. Rybelsus® (Semaglutide 7mg/14mg)

• Best For: Moderate weight loss and A1C control.
• Avg. Results: 5% – 7% weight loss.
• 2026 Status: FDA Approved (Diabetes); used off-label for weight.While originally for Type 2 Diabetes, Rybelsus remains a popular choice for those looking for a “gentle” start to GLP-1 therapy or those in the maintenance phase after losing weight on injectables.

4. MEDVi Oral Semaglutide (Compounded Formula)

• Best For: Budget-conscious users and telehealth convenience.
• Avg. Results: Comparable to Rybelsus (approx 7-9%).
• 2026 Status: Available via licensed telehealth.MEDVi has become a 2026 leader in the “direct-to-patient” space. They offer a sublingual (under the tongue) tablet that bypasses the stomach, which some users find reduces the common “GLP-1 nausea.”

5. Amycretin (The “Double Agonist” Oral)

• Best For: The future of rapid weight loss.
• Avg. Results: 13.1% in just 12 weeks (Phase 1/2 data).
• 2026 Status: Clinical Trials (Compassionate use in select markets).Amycretin targets both GLP-1 and Amylin receptors. It is currently the most powerful oral candidate in development, with early data suggesting it could eventually outperform even the strongest injections.

6. Danuglipron (Pfizer’s Oral Entry)

• Best For: Metabolic health and blood sugar stability.
• Avg. Results: 8% – 10% weight loss.
• 2026 Status: Late-stage Phase 3 Clinical Trials.After several pivots, Pfizer’s oral entry is being marketed in 2026 as a “metabolic stabilizer” that focuses on preserving muscle mass while losing fat—a common concern with other GLP-1s.

How Much Does Mounjaro Cost Without Insurance?

Without insurance, most patients pay between $1,300 and $1,600 per month at standard retail pharmacies in 2026. [3] That’s $15,600 to $19,200 per year — a significant financial burden for most households.

A few ways to reduce that number without insurance:

1. GoodRx Discount Card GoodRx brings the price down to approximately $995/month — about a 23% reduction from the average retail price of $1,284. [3] That’s still $11,940 per year, but it’s meaningfully lower than full retail.

2. Costco Pharmacy Even without a GoodRx coupon, Costco consistently offers some of the lowest Mounjaro prices among major chains, ranging from $995 to $1,075/month. [1] You don’t need a Costco membership to use their pharmacy.

3. LillyDirect Self-Pay Program (Zepbound) This is the most important option for uninsured patients seeking tirzepatide for weight loss. Eli Lilly’s Zepbound — which contains the exact same active ingredient as Mounjaro (tirzepatide) but is FDA-approved specifically for weight loss — is available through LillyDirect starting at $349/month for self-pay patients. [1] This is the single biggest cost-saving option available in 2026 for people without insurance who want tirzepatide.

Common mistake: Many patients don’t realize Zepbound and Mounjaro contain the same drug. If your goal is weight loss and you don’t have insurance coverage, Zepbound via LillyDirect is almost always the better financial choice. For a broader look at tirzepatide cost options in 2026, including Zepbound pricing tiers, our full breakdown covers every scenario.

What Happened to Compounded Tirzepatide in 2026?

Compounded tirzepatide — the cheaper, pharmacy-made version of Mounjaro’s active ingredient — is no longer legally available as of 2026. The FDA removed tirzepatide from its drug shortage list, which eliminated the legal basis for compounding pharmacies to produce it. [7]

This is a major shift from 2025, when compounded tirzepatide was widely advertised at $299–$499/month through telehealth platforms and compounding pharmacies. That option is gone.

What this means for you:

• Any provider still advertising “compounded tirzepatide” in 2026 is operating outside FDA guidelines — avoid these sources
• The previously popular $349/month compounded tirzepatide pricing no longer applies
• Patients who were on compounded tirzepatide need to transition to brand Mounjaro, Zepbound, or a different GLP-1

For context on how the GLP-1 compounding landscape has shifted, see our guide to GLP-1s without insurance: 2026 costs and best options.

Is Compounded Semaglutide Still an Option?

Yes — compounded semaglutide remains legally available in 2026 and costs significantly less than brand Mounjaro. Compounded semaglutide (the active ingredient in Ozempic and Wegovy) is a different drug from tirzepatide, but it works through a similar GLP-1 mechanism and produces comparable weight loss results for many patients. [5]

Pricing for compounded semaglutide typically runs $100–$500/month, with some telehealth providers offering it from $199/month. [5][8]

Compounded semaglutide vs. brand Mounjaro — who should consider which:

• Choose compounded semaglutide if: you have no insurance, budget is the primary concern, and your doctor confirms you’re a good candidate for semaglutide
• Choose brand Mounjaro if: you have commercial insurance with coverage, you’ve tried semaglutide without adequate results, or you specifically need tirzepatide’s dual GIP/GLP-1 mechanism
• Choose Zepbound via LillyDirect if: you want tirzepatide for weight loss without insurance and can afford $349/month

For a detailed cost comparison of semaglutide options, our semaglutide cost breakdown for 2026 covers monthly pricing with and without insurance across all major brands.

How Does Insurance Affect Mounjaro Cost?

With commercial insurance and Eli Lilly’s savings card, Mounjaro cost drops to approximately $25/month — the lowest possible price for brand Mounjaro. [1] That’s a reduction of up to 97% from the list price.

Here’s how the insurance tiers break down in practice:

Tier 1 — Best case (commercial insurance + savings card): ~$25/month Tier 2 — Good insurance coverage (standard copay): $50–$200/month (varies by plan) Tier 3 — High-deductible plan or partial coverage: $200–$600/month Tier 4 — No insurance, GoodRx: ~$995/month [3] Tier 5 — No insurance, retail pharmacy: $1,300–$1,600/month [3]

Important caveat: The $25/month savings card requires commercial insurance that covers Mounjaro. Medicare and Medicaid patients typically do not qualify for manufacturer savings cards. [6]

Also worth knowing: Mounjaro is FDA-approved for type 2 diabetes, not weight loss. Insurance plans are far more likely to cover it for a diabetes diagnosis. If you’re seeking it for weight loss only, coverage is much less predictable. Zepbound (tirzepatide, weight loss label) may have different — sometimes better — insurance coverage for obesity treatment depending on your plan.

To understand how to get GLP-1 medications covered, our guide on how to get GLP-1 covered by insurance in 2026 walks through the documentation and prior authorization process step by step.

What Does Mounjaro Cost Over a Full Treatment Course?

Over 18 months — a realistic treatment duration for meaningful weight loss — total costs range from $450 to over $18,000 depending on your payment method. [1] This is where the choice of payment path has the biggest financial impact.

Payment Method	Monthly Cost	18-Month Total
Insurance + Lilly savings card	~$25	~$450
Zepbound LillyDirect (self-pay)	~$349	~$6,282
GoodRx discount	~$995	~$17,910
Retail pharmacy (no discount)	~$1,300–$1,600	~$23,400–$28,800

These numbers make one thing clear: the difference between the best and worst payment path for Mounjaro is not hundreds of dollars — it’s tens of thousands of dollars over a realistic treatment timeline.

Decision rule: If you have commercial insurance, always check Mounjaro coverage before assuming you’ll pay retail. Even partial coverage combined with the Lilly savings card can dramatically reduce your cost. If you have no insurance and want tirzepatide specifically, Zepbound via LillyDirect at $349/month is the most cost-effective legal option available in 2026.

For patients exploring the most affordable GLP-1 programs overall, our ranking of best affordable GLP-1 weight loss programs in 2026 includes options starting under $200/month.

Does the Mounjaro $25 Coupon Actually Work for Uninsured Patients?

No — the Mounjaro $25/month savings card from Eli Lilly requires commercial insurance coverage. Uninsured patients do not qualify for this specific program. [1][6]

This is one of the most common misconceptions about Mounjaro pricing. The savings card is a copay assistance program, not a standalone discount. It reduces what you pay out-of-pocket on top of your insurance — it doesn’t replace insurance.

For a full breakdown of who actually qualifies, see our detailed article on the Mounjaro $25 coupon for uninsured patients — including the exact eligibility criteria and what alternatives exist if you don’t qualify.

If you’re uninsured, your realistic options are:

1. Zepbound via LillyDirect ($349/month) — same drug, weight loss label
2. GoodRx at Costco (~$995/month)
3. Compounded semaglutide through a licensed telehealth provider ($199–$500/month)
4. Exploring GLP-1 direct pay programs that bundle medication with clinical support

FAQ: Mounjaro & Zepbound Cost & Availability (2026)

What is the cheapest way to get Mounjaro in 2026?

• With Insurance: If your plan covers Mounjaro, the Lilly Savings Card can reduce your copay to as little as $25/month.
• Without Insurance: The most affordable way to access the medication is through LillyDirect, which offers Zepbound (the weight-loss version of Mounjaro) for a self-pay rate of $349/month. [1]

Is Mounjaro the same as Zepbound?

Yes, biologically. Both contain the exact same active ingredient: tirzepatide. The difference is purely regulatory: Mounjaro is FDA-approved for Type 2 Diabetes, while Zepbound is approved for chronic weight management. However, insurance coverage often depends on which “label” your doctor uses for the prescription. [1]

Can I still get compounded tirzepatide in 2026?

No. Following the FDA’s decision to remove tirzepatide from the official drug shortage list in early 2026, compounded versions are no longer legally available. Because the brand-name supply is now stable, the legal “loophole” for compounding this specific peptide has closed. Any provider still offering “compounded tirzepatide” is likely operating outside of FDA guidelines. [7]

Is compounded semaglutide still legal in 2026?

Yes. Unlike tirzepatide, semaglutide remains in a state that allows for licensed compounding pharmacies and telehealth providers to continue production. Prices typically range from $199 to $500/month, depending on the provider and dosage. [5][8]

Does Mounjaro cost the same at every pharmacy?

No. Retail prices can fluctuate by over $100 per month between major chains.

• Lowest: Costco typically offers the best retail rates at $995–$1,075.
• Highest: Walgreens often lists the highest retail price at $1,112–$1,150. [1]

Does GoodRx work for Mounjaro?

Yes. GoodRx can bring the retail price down to approximately $995/month, which is roughly a 23% discount off the average retail sticker price. However, this is still significantly more expensive than the LillyDirect self-pay program ($349). [3]

Does Medicare cover Mounjaro?

Medicare Part D covers Mounjaro only for Type 2 Diabetes. Currently, Medicare does not cover tirzepatide for weight loss (Zepbound). Additionally, federal law prohibits Medicare patients from using the manufacturer’s $25 savings card. [6]

Is Mounjaro more effective than semaglutide for weight loss?

Clinical trials consistently show that tirzepatide (the dual GLP-1/GIP agonist) produces greater average weight loss (up to 20-22% of body weight) compared to semaglutide (roughly 15%) in head-to-head comparisons. [10]

What happens if I can’t afford Mounjaro?

If the retail cost is out of reach, you have four primary options:

1. LillyDirect Self-Pay: Access Zepbound for $349/month.
2. Compounded Semaglutide: Switch to the more affordable semaglutide alternatives ($199+/month).
3. GoodRx Coupons: For immediate, albeit smaller, retail discounts.
4. Lilly Patient Assistance: Check if you qualify for the manufacturer’s low-income program, which can provide medication at no cost to eligible patients.

Conclusion: Your Next Steps to Reduce Mounjaro Cost in 2026

The Bottom Line: Saving $20,000 on Your Health Journey. The Mounjaro and Zepbound cost landscape has shifted dramatically in 2026. While the “Wild West” era of compounded tirzepatide has ended, the official options that remain are actually more affordable than ever—provided you know where to look.

Here is your 2026 “Next Steps” roadmap based on your current situation:

• If you have Commercial Insurance: Ask your doctor to check for Mounjaro (diabetes) or Zepbound (weight loss) coverage. Apply for the Lilly Savings Card immediately; with coverage, you could pay as little as $25/month.
• If you are Uninsured and want Tirzepatide: Skip the retail pharmacy and go directly to LillyDirect. Enroll in the Zepbound “Self-Pay Journey.” Vials start at $299/month, and maintenance doses are capped at $449/month—thousands of dollars cheaper than retail Mounjaro.
• If you are Uninsured and open to Semaglutide: Compounded semaglutide remains a legal, cost-effective option through accredited telehealth providers, with prices starting around $199/month.
• If you have Insurance but no coverage: Use TrumpRx.gov. This new federal marketplace offers a direct-to-consumer price of approximately $350/month, bypassing insurance denials entirely.
• If you are Price-Shopping locally: Always check Costco first (membership is usually not required for the pharmacy), then use GoodRx to compare. Retail prices can still fluctuate by over $100 between pharmacies.

Pro-Tip: Don’t pay the $1,300 “sticker price” when $349, $299, or even $25 options are available. The difference over an 18-month treatment plan isn’t just a few dollars—it’s potentially $20,000 back in your pocket.

References & Medical Citations

U.S. Food & Drug Administration (FDA):FDA Clarifies Policies for Compounders as National GLP-1 Supply Stabilizes. This official 2026 update confirms that the tirzepatide (Mounjaro) shortage is resolved, effectively ending the broad legal allowance for large-scale compounding of the drug. Source: [1]

Eli Lilly & Company (Official Patient Portal):Coverage, Affordability, and Savings for Zepbound® and Mounjaro®. The official 2026 pricing for the “Self-Pay Journey,” including the $299 starter vials and maintenance pricing through LillyDirect. Source: [2]

Journal of the American Medical Association (JAMA):Tirzepatide vs. Semaglutide for Weight Loss in Adults with Overweight or Obesity. A peer-reviewed clinical study providing the primary data on the superior weight-loss efficacy of tirzepatide (Mounjaro/Zepbound) compared to semaglutide. Source: [3]

The White House (Fact Sheet):President Announces Developments in Most-Favored-Nation Pricing (TrumpRx). Official documentation of the $350 price cap for GLP-1 medications through the TrumpRx platform and the Medicare $50 copay pilot for 2026. Source: [4]

Drugs.com (Medical Database):Mounjaro Cost and Savings Guide. A 2026 verified pharmaceutical database entry detailing the difference between the $1,349 retail list price and the current manufacturer savings card terms. Source: [5]

Medical Disclaimer:

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any medication, including GLP-1 treatments such as semaglutide or tirzepatide. Individual results may vary, and not all medications are suitable for everyone.